Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
News Feb 17, 2015
Developed and tested in collaboration with Assistant Professor of Biomedical Engineering, and molecular, cellular & developmental biology Kathryn Miller-Jensen, the device consists of a glass slide attached to a microchamber array; the glass slide is striped with 15 different bands of antibodies — three per band for fourteen of the stripes, with an additional control band. The bands change colors in the presence of various immune effector function proteins, including pro-inflammatory cytokines, chemokines, cytolytic enzymes, and growth factors.
The researchers also used their device to generate novel insights into how immune cells respond to pathogens. In particular, distinct subpopulations of genetically identical immune cells exhibited varied reactions to pathogen stimulation — reactions that though diverse appeared dynamically structured instead of randomized. For example, the researchers identified one subpopulation that secreted a macrophage migration inhibitory factor that potentiates the production of a range of inflammatory cytokines.
“This research opens the door for deep functional phenotyping and comprehensive dissection of immune functional states of single cells,” said Fan. “We hope that this might soon be a common tool in the clinic, where these capabilities could be key to, say, measuring the effectiveness and toxic effect of cancer immunotherapy on an individual patient. In this way, medicines might be tailored to the individual’s cellular activation for optimal results and minimal side effects.
Additional authors of the research include Yao Lu, Qiong Xue, Markus R. Eisele, Endah S. Sulistijo, and Lin Han of Yale; Kara Brower of IsoPlexis; and El-ad David Amir and Dana Pe’er of Columbia University.
This research resulted from a project funded through the NIH Program “Library of Integrated Network-based Cellular Signatures” for which Fan and Miller-Jensen were principal investigators. It was also supported by the DFCI Physical Oncology Cancer Center where Fan has been directing its Single Cell Analysis core.
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Improved Capture of Free-Floating Cancer Cells, Cast-Off from TumorsNews
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center and University of Wisconsin-Madison have demonstrated improved methods of capturing free-floating cancer cells that are cast-off from tumors, and circulating in the blood.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Applied Sciences Biopharma Cancer Research Cell Science Diagnostics Informatics Proteomics & Metabolomics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE